Literature DB >> 17074686

Performance characteristics of six IMMULITE 2000 TORCH assays.

William E Owen1, Thomas B Martins, Christine M Litwin, William L Roberts.   

Abstract

TORCH is an acronym for Toxoplasma gondii (Toxo), other microorganisms (eg, syphilis), rubella virus (RV), cytomegalovirus (CMV), and herpes simplex virus (HSV) that are associated with congenital abnormalities from maternal infection. We evaluated linearity, imprecision, and comparison with commercially available methods of the IMMULITE 2000 (Diagnostic Products, Los Angeles, CA) Toxo IgG, Toxo IgM, RV IgG, RV IgM, CMV IgG, and HSV IgG assays. Linearity and imprecision results were acceptable. The IMMULITE 2000 assays show good concordance with other commercially available methods except for Toxo IgM and RV IgM. Toxo IgM showed better concordance with a consensus of 3 of 4 (Access, Beckman Coulter, Fullerton, CA; IMMULITE 2000; Platelia, Bio-Rad Laboratories Diagnostics Group, Redmond, WA; and Vidas, bioMerieux, Hazelwood, MO) assays than with Access alone. The RV IgM assay showed better concordance with the Zeus method than with the Diamedix method (Diamedix, Miami, FL). The IMMULITE 2000 TORCH assays studied show acceptable performance and are suitable for routine clinical use. Some commercial assays for Toxo IgM and RV IgM show rather poor concordance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074686     DOI: 10.1309/KUA926D3YAPFYQG8

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.

Authors:  Arnaud Maudry; Gautier Chene; Rémi Chatelain; Hugues Patural; Bahrie Bellete; Bernard Tisseur; Jamal Hafid; Hélène Raberin; Sophie Beretta; Roger Tran Manh Sung; Georges Belot; Pierre Flori
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

2.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

3.  Performance characteristics of current-generation Immulite 2000 TORCH Assays.

Authors:  A R Centonze; E Tonolli; R Fontana
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

4.  Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.

Authors:  Harry E Prince; Mary Lapé-Nixon; Susan M Novak-Weekley
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

5.  Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy.

Authors:  B Pinto; B Castagna; R Mattei; R Bruzzi; L Chiumiento; R Cristofani; W Buffolano; F Bruschi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

6.  Evaluation of DPC immulite 2000 Toxoplasma quantitative IgG/IgM kits for automated toxoplasmosis serology with immulite 2000.

Authors:  Florence Robert-Gangneux; Chantal Bourhis; Sylviane Chevrier; Jean-Pierre Gangneux
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 7.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

8.  Evaluation of a novel array-based toxoplasma, rubella, cytomegalovirus, and herpes simplex virus IgG enzyme linked immunosorbent assay and its comparison with virion/serion enzyme linked immunosorbent assays.

Authors:  Dongsheng Wu; Yuanjian Wu; Liuhong Wang; Weidong Xu; Qiao Zhong
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

9.  [Microbiological diagnosis: Etiologic driven and syndrome driven].

Authors:  F Gouriet; D Raoult
Journal:  Antibiotiques (Paris)       Date:  2008-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.